Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanespimycin in Metastatic Melanoma
NCT00087386Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Jun 2004
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tanespimycin in melanoma, sponsored by National Cancer Institute. Started Jun 2004; status: terminated.
02
Drugs
tanespimycin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00087386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087386.